Anastasia Albanese-O'Neill discusses a significant unmet need in the treatment of type 1 diabetes.
Type 1 Diabetes
Advertisement
The FDA rejected Zynquista as an add-on to insulin therapy for adults with type 1 diabetes and CKD.
KDIGO classifications for the burden and impact of renal and CV adverse outcomes in type 1 diabetes are underutilized.
A retrospective study examined whether SGLT2is are associated with cardiorenal benefits for patients with type 1 diabetes.
Black children with type 1 diabetes (T1D) experience disparities in health outcomes compared with other racial and ...
Screening recommendations for kidney disease include annual testing for albuminuria following 5 years duration of type 1 ...
Type 1 diabetes may be preventing by a new drug candidate that inhibits the gene associated with the onset of the ...
Type 1 diabetes is diagnosed primarily in children and young adults, and patients with diabetes commonly develop ...
Patients with diabetes have a much higher risk of complications following coronary artery bypass surgery compared with ...
Both pancreas transplantation alone (PTA) and islet cell transplantation (ICT) have been associated with peri-operative ...
A study assessed the impact of advanced carbohydrate counting versus standard nutrition on metabolic control and quality ...
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.